drugset / Trial / NCT02745639
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer
NaSingle-groupOpen-labelTreatment
Summary
This was a prospective phase II study on patients with locally advanced rectal cancer or local recurrence, to evaluate the pathological response and resectability of a neoadjuvant treatment based on the use of a combined treatment with VMAT-SIB and two drugs chemotherapy ( XELOX).
Timeline
- Start
- 2010-02
- Primary completion
- 2013-11
- Completion
- 2015-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 825 mg/m2 | — |
| Subject | Oxaliplatin | Small molecule | 130 mg/m2 | — |